0001127602-24-016175.txt : 20240521
0001127602-24-016175.hdr.sgml : 20240521
20240521180156
ACCESSION NUMBER: 0001127602-24-016175
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240517
FILED AS OF DATE: 20240521
DATE AS OF CHANGE: 20240521
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Strong Stewart W
CENTRAL INDEX KEY: 0001420910
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14041
FILM NUMBER: 24971060
MAIL ADDRESS:
STREET 1: C/O HAEMONETICS CORPORATION
STREET 2: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HAEMONETICS CORP
CENTRAL INDEX KEY: 0000313143
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 042882273
STATE OF INCORPORATION: MA
FISCAL YEAR END: 0330
BUSINESS ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 7818487100
MAIL ADDRESS:
STREET 1: 125 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-05-17
0000313143
HAEMONETICS CORP
HAE
0001420910
Strong Stewart W
125 SUMMER STREET
BOSTON
MA
02110
1
President, Global Hospital
1
Common Stock
2024-05-17
4
F
0
284
95.73
D
15324
D
Common Stock
2024-05-17
4
A
0
2872
A
18196
D
Common Stock
2024-05-20
4
M
0
2241
56.57
A
20437
D
Common Stock
2024-05-20
4
F
0
1555
95.08
D
18882
D
Common Stock
2024-05-20
4
S
0
686
95.11
D
18196
D
Non-qualified Stock Option (Right to Buy)
95.73
2024-05-17
4
A
0
6313
0
A
2031-05-17
Common Stock
6313
6313
D
Non-qualified Stock Option (Right to Buy)
56.57
2024-05-20
4
M
0
2241
0
D
2023-05-18
2028-05-18
Common Stock
2241
2242
D
Represents shares withheld for tax obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I.
This number includes unvested RSUs previously reported.
The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest in three equal annual installments beginning on the first anniversary of the date of grant.
Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.
Transaction pursuant to an existing 10b5-1 trading plan dated June 12, 2023 (fully executed as of June 12, 2023).
Represents shares withheld for tax obligations and for payment of the exercise price on exercised stock options reported in Table I.
Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.
Reflects options granted on May 18, 2021 that vest in annual increments of 25% beginning on the first anniversary of the date of grant.
/s/ Thomas V. Powers, attorney-in-fact for Mr. Strong
2024-05-21